NG
Northstar Group Portfolio holdings
AUM
$648M
This Quarter Return
+7.76%
1 Year Return
+15.46%
3 Year Return
+67.92%
5 Year Return
+114.96%
10 Year Return
+255.05%
AUM
$460M
AUM Growth
+$460M
(+9.1%)
Cap. Flow
+$4.27M
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
56.06%
Holding
150
New
7
Increased
33
Reduced
61
Closed
5
Top Buys
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$9.13M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$2.01M |
| 3 |
Markel Group
MKL
|
$815K |
| 4 |
Vanguard Value ETF
VTV
|
$649K |
| 5 |
Vanguard Total International Stock ETF
VXUS
|
$411K |
Top Sells
Sector Composition
| 1 | Financials | 23.2% |
| 2 | Technology | 11.84% |
| 3 | Communication Services | 7.92% |
| 4 | Consumer Staples | 7.1% |
| 5 | Consumer Discretionary | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Exact Sciences
EXAS
$8.98B
| $357K | 0.08% |
4,821
| – | – |
|
102
Bank of America
BAC
$376B
| $344K | 0.07% |
10,209
-3,933
| -28% | -$132K |
|
103
Industrial Select Sector SPDR Fund
XLI
$23.3B
| $342K | 0.07% |
2,999
| – | – |
|
104
Cigna
CI
$80.3B
| $337K | 0.07% |
1,125
| – | – |
|
105
ON Semiconductor
ON
$20.3B
| $337K | 0.07% |
4,033
| – | – |
|
106
Occidental Petroleum
OXY
$46.9B
| $336K | 0.07% |
5,633
+102
| +2% | +$6.09K |
|
107
UnitedHealth
UNH
$281B
| $331K | 0.07% |
629
| – | – |
|
108
Golub Capital BDC
GBDC
$3.97B
| $325K | 0.07% |
21,538
| – | – |
|
109
Vanguard S&P Small-Cap 600 ETF
VIOO
$3.03B
| $325K | 0.07% |
3,273
+196
| +6% | +$19.4K |
|
110
Vanguard Extended Market ETF
VXF
$23.9B
| $323K | 0.07% |
1,965
| – | – |
|
111
Thermo Fisher Scientific
TMO
$186B
| $320K | 0.07% |
603
| – | – |
|
112
Kenvue
KVUE
$39.7B
| $315K | 0.07% |
14,616
+4
| +0% | +$86 |
|
113
FedEx
FDX
$54.5B
| $306K | 0.07% |
1,210
-14
| -1% | -$3.54K |
|
114
D.R. Horton
DHI
$50.5B
| $302K | 0.07% |
1,988
| – | – |
|
115
SPDR Portfolio S&P 500 ETF
SPLG
$83.6B
| $302K | 0.07% |
5,400
| – | – |
|
116
Hershey
HSY
$37.3B
| $299K | 0.06% |
1,602
| – | – |
|
117
Bristol-Myers Squibb
BMY
$96B
| $286K | 0.06% |
5,571
-1,169
| -17% | -$60K |
|
118
3M
MMM
$82.8B
| $283K | 0.06% |
2,593
-445
| -15% | -$48.6K |
|
119
Accenture
ACN
$162B
| $280K | 0.06% |
799
| – | – |
|
120
Novartis
NVS
$245B
| $276K | 0.06% |
2,729
| – | – |
|
121
Bank of New York Mellon
BK
$74.5B
| $273K | 0.06% |
5,251
-2,726
| -34% | -$142K |
|
122
Broadcom
AVGO
$1.4T
| $270K | 0.06% |
242
-10
| -4% | -$11.2K |
|
123
Philip Morris
PM
$260B
| $268K | 0.06% |
2,849
| – | – |
|
124
Tesla
TSLA
$1.08T
| $267K | 0.06% |
1,076
| – | – |
|
125
Lam Research
LRCX
$127B
| $266K | 0.06% |
340
| – | – |
|